Advance amount related to milestone payment.

No definition available.

Name:	LIXT_AdvanceAmountRelatedToMilestonePayment
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Agreement term description.

+ References

No definition available.

+ Details

Name:	LIXT_AgreementTermDescription
Namespace Prefix:	LIXT_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount related to milestone payment.

+ References

No definition available.

+ Details

Name:	LIXT_AmountRelatedToMilestonePayment
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Company is obligated to pay annual license maintenance fee.

+ References

No definition available.

+ Details

Name:	LIXT_AnnualLicenseMaintenanceFee
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Consulting and advisory quarterly cash fee.

+ References

No definition available.

+ Details

Name:	LIXT_ConsultingAndAdvisoryCashFee
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Contract price.

+ References

No definition available.

+ Details

Name:	LIXT_ContractPrice
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Company is obligated to pay non refundable license issue fee..

+ References

No definition available.

+ Details

Name:	LIXT_NonRefundableLicenseIssueFee
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Company agreed to pay non-refundable milestone payments which cannot be credited against earned royalties payable by the Company, based on reaching various clinical and commercial milestones.

+ References

No definition available.

+ Details

Name:	LIXT_PaymentsOnNonrefundableMilestone
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Reimbursement expense.

+ References

No definition available.

+ Details

Name:	LIXT_ReimbursementExpense
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3

+ Details

Name:	us-gaap_ContractualObligation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(17))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(10))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1

+ Details

Name:	us-gaap_DeferredCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of expense for employee benefit and equity-based compensation.

+ References

No definition available.

+ Details

Name:	us-gaap_EmployeeBenefitsAndShareBasedCompensation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(4))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_OfficersCompensation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.

+ References

No definition available.

+ Details

Name:	us-gaap_OperatingCostsAndExpenses
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.

+ References

No definition available.

+ Details

Name:	us-gaap_OtherCommitment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Description of the nature and terms of commitment.

+ References

No definition available.

+ Details

Name:	us-gaap_OtherCommitmentsDescription
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Cash payments to lessor's for use of assets under operating leases.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (g)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-25

+ Details

Name:	us-gaap_PaymentsForRent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of cash paid for royalties during the current period.

+ References

+ Details

Name:	us-gaap_PaymentsForRoyalties
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 730
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482916/730-10-50-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 912
-SubTopic 730
-Name Accounting Standards Codification
-Section 25
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482517/912-730-25-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481283/985-20-50-1

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.

+ References

No definition available.

+ Details

Name:	us-gaap_SalariesWagesAndOfficersCompensation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	srt_TitleOfIndividualAxis=LIXT_FormanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_TitleOfIndividualAxis=srt_OfficerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=LIXT_CityOfHopeNationalMedicalCenterMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_GrupoEspanolDeInvestigacionEnSarcomasMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_NDAConsultingCorpMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_ClinicalTrialResearchAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_OtherClinicalAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_CollaborationAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_BioPharmaWorksLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_ClinicalResearchSupportAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_WorkOrderAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=LIXT_TheradexSystemsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_ExclusiveLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VestingAxis=LIXT_FirstFourYearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VestingAxis=LIXT_FiveYearsAndThereafterMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=LIXT_MoffittCancerCenterandResearchInstituteHospitalIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_EmploymentAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_TitleOfIndividualAxis=LIXT_ExecutiveOfficersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_TitleOfIndividualAxis=LIXT_Dr.JamesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_DevelopmentCollaborationAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=LIXT_NetherlandsCancerInstituteMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_MRIGlobalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies (Details Narrative) - USD ($)											2 Months Ended	3 Months Ended
	Apr. 17, 2023	Nov. 06, 2022	Oct. 01, 2022	Jun. 10, 2022	Apr. 09, 2021	Feb. 05, 2021	Sep. 12, 2018	Aug. 20, 2018	Sep. 14, 2015	Dec. 24, 2013	Aug. 31, 2020	Mar. 31, 2023	Mar. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Contractual commitment												$ 7,900,000
Research and development costs												189,085	$ 458,450
Aggregate commitments expected												53,000
Forman [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Compensation		$ 200,000
Paid office rent			$ 600									2,583
Officer [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Compensation		$ 800,000
City of Hope [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Aggregate commitments expected												273,000
GEIS [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Amount related to milestone payment												415,823
NDA Consulting Corp [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Consulting and advisory fee										$ 4,000		4,000	4,000
Clinical Trial Research Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Advance amount related to milestone payment												6,000	3,332
Research and development costs												$ 137,074
Aggregate commitments expected, description												The Company’s aggregate commitment pursuant to this agreement, less amounts previously paid to date, totaled approximately $575,000 as of March 31, 2023, which is expected to be incurred through December 31, 2025
Aggregate commitments expected												$ 575,000
Other Clinical Agreements [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Research and development costs												1,144,000
Collaboration Agreement [Member] \| GEIS [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Research and development costs												415,823
Aggregate commitments expected												3,792,000
Collaboration Agreement [Member] \| Bio Pharma Works LLC [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Consulting and advisory fee									$ 10,000
Reimbursed expense												30,000	30,000
Clinical Research Support Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Aggregate commitments expected												800,000
Clinical Research Support Agreement [Member] \| City of Hope [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Research and development costs												69,001	0
Aggregate commitments expected												2,433,000
Total costs												447,512
Work Order Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Research and development costs												136,575
Aggregate commitments expected												826,000
Work Order Agreement [Member] \| City of Hope [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Advance amount related to milestone payment												5,553	4,500
Research and development costs						$ 335,000
Aggregate commitments expected												63,994
Work Order Agreement [Member] \| Theradex Systems, Inc. [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Research and development costs							$ 954,000					9,287	3,281
Exclusive License Agreement [Member] \| First Four Years [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Minimum payments for royalties												50,000
Exclusive License Agreement [Member] \| Five Years And Thereafter [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Minimum payments for royalties												100,000
Exclusive License Agreement [Member] \| Moffitt Cancer Center and Research Institute Hospital Inc [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Non refundable license issue fee								$ 25,000
Maintenance fee								25,000
Payment on non refundable milestone								$ 1,897,000
Operating costs and expenses												6,165	6,165
Employment Agreement [Member] \| Executive Officers [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Salary and compensation											$ 640,000
Agreement term description											one-year periods
Employment Agreement [Member] \| Dr.James [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Annual compensation					$ 775,000
Development Collaboration Agreement [Member] \| Netherlands Cancer Institute [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Advance amount related to milestone payment												52,203	54,230
Research and development costs												416,518
Aggregate commitments expected												53,000
MRI Global [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Advance amount related to milestone payment												3,173	$ 756
Research and development costs												$ 222,784
Contract price	$ 326,274			$ 273,980